ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항오심제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.3%의 연평균 성장률(CAGR)로 43억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 암 치료에 대한 채택 증가, 안전한 성분에 대한 규제 강화, 원격의료 및 전자 처방의 성장, 최소침습 수술의 확대, 병원 인프라의 발전 등과 관련이 있을 것으로 보입니다. 예측 기간 동안 주요 동향으로는 디지털 헬스 솔루션의 통합, 표적 치료의 개발, 맞춤형 의료로의 전환, 치료용 경피 패치 채택, 약물 제제의 발전 등을 들 수 있습니다.
건강에 해로운 식습관의 증가는 향후 항오심제 시장의 성장을 견인할 것으로 예상됩니다. 건강에 해로운 식단은 일반적으로 가공식품, 설탕, 건강에 해로운 지방, 소금을 많이 섭취하는 반면 비타민, 미네랄, 식이섬유와 같은 필수 영양소가 부족합니다. 건강한 대체 식품보다 저렴하고 편리한 가공식품과 패스트푸드에 대한 선호도가 높아지면서 이러한 추세에 박차를 가하고 있습니다. 이러한 식습관은 위장 불편감, 위산 역류, 소화불량, 메스꺼움 등을 유발하는 경우가 많습니다. 구토방지제 등의 항오심제는 멀미, 위장 문제, 약물 부작용 등 근본적인 원인을 해결함으로써 이러한 증상을 완화하는 데 도움이 됩니다. 이러한 약물은 메스꺼움을 유발하는 뇌 신호를 차단하거나 위를 진정시켜 구토 충동을 억제함으로써 효과를 발휘합니다. 예를 들어, 2025년 4월 American Journal of Preventive Medicine에 따르면, 미국에서는 연간 12만 4,000명 이상이 초가공 식품과 관련하여 사망하고 있습니다. 건강에 해로운 식습관이 계속 증가함에 따라 항오심제에 대한 수요도 증가하고 있습니다.
항오심제 시장의 주요 기업들은 화학요법으로 인한 항오심제와 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 이러한 약물은 암 화학요법으로 인한 메스꺼움과 구토를 예방하거나 완화하기 위해 특별히 고안되었으며, 종종 뇌의 세로토닌 수용체와 뉴로키닌 수용체를 표적으로 삼고 있습니다. 예를 들어, 2023년 1월 인도 제약회사 글렌마크 파마슈티컬스(Glenmark Pharmaceuticals)는 화학요법 유발성 메스꺼움과 구토(CINV)를 예방하기 위해 포스네츠피탄트와 팔로노세트론을 혼합한 즉시 희석할 수 있는 정맥주사제 AKYNZEO I.V.를 출시했습니다. 이 단일 정맥주사제는 CINV의 급성기 및 지연기를 예방하고, 여러 구토방지제의 필요성을 줄여 치료를 간소화하며, 환자의 순응도를 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 항오심제 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 항오심제 시장 : 성장률 분석
세계의 항오심제 시장 규모·성장률 : 실적치, 2019-2024년
세계의 항오심제 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
세계의 항오심제 시장 : 총유효과 시장(TAM)
제6장 시장 세분화
세계의 항오심제 시장 : 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
길항제
항히스타민제
카나비노이드
기타 종류
세계의 항오심제 시장 : 적응증별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
종양
위식도역류질환
멀미·배멀미
기타 적응증
세계의 항오심제 시장 : 투여 경로별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
경구제
주사제
경피제
직장
기타 투여 경로
세계의 항오심제 시장 : 유통 채널별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
소매 약국
병원 약국
온라인 약국
기타 유통 채널
세계의 항오심제 시장 : 최종사용자별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
병원
재택의료
외래 수술 센터
장기간병 시설
개인소비자
세계의 항오심제 시장, 길항제 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
세로토닌 길항제
뉴로키닌 1(NK1) 수용체 길항제
도파민 길항제
세계의 항오심제 시장, 항히스타민제 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
H1 항히스타민제
H2 항히스타민제
세계의 항오심제 시장, 카나비노이드 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
THC(테트라하이드로칸나비놀)
CBD(칸나비디올)
세계의 항오심제 시장, 기타 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
코르티코스테로이드
벤조디아제핀
생강 기반 약
제7장 지역별·국가별 분석
세계의 항오심제 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
세계의 항오심제 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
항오심제 시장 : 경쟁 구도
항오심제 시장 : 기업 개요
Pfizer Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
Johnson & Johnson(개요, 제품 및 서비스, 전략, 재무 분석)
AbbVie Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
Bayer Aktiengesellschaft(개요, 제품 및 서비스, 전략, 재무 분석)
Merck & Co. Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
Sanofi S.A.
Novartis AG
AstraZeneca PLC
Abbott Laboratories
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Helsinn Healthcare SA
Mylan N.V.
Viatris Inc.
Baxter International Inc.
Teva Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Zydus Lifesciences Limited
Amneal Pharmaceuticals Inc.
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
항오심제 시장 : 최신 기회를 제공하는 국가(2029년)
항오심제 시장 : 최신 기회를 제공하는 부문(2029년)
항오심제 시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Nausea medication is a drug designed to counteract the body's emetic response by targeting specific receptors in the brain or gastrointestinal tract that cause nausea and vomiting. It is used to reduce or prevent nausea and vomiting resulting from conditions such as motion sickness, anesthesia, chemotherapy, gastrointestinal disorders, or pregnancy-related issues.
The main types of nausea medications are antagonists, cannabinoids, and others. Antagonists are substances (typically drugs) that bind to receptors in the body to block or lessen a biological response by preventing the action of other substances, such as hormones or neurotransmitters. These medications are used for various conditions, including oncology, gastroesophageal reflux disease, motion sickness, seasickness, and more. They can be administered through different routes, such as oral, injectable, transdermal, and rectal. These medications are available at retail pharmacies, hospital pharmacies, online pharmacies, and other outlets, catering to various users, including hospitals, home care settings, ambulatory surgical centers, long-term care facilities, and individual consumers.
The nausea medicine market research report is one of a series of new reports from The Business Research Company that provides nausea medicine market statistics, including nausea medicine industry global market size, regional shares, competitors with a nausea medicine market share, detailed nausea medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nausea medicine industry. This nausea medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nausea medicine market size has grown strongly in recent years. It will grow from $3.02 billion in 2024 to $3.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the increase in chemotherapy cases, greater awareness of pregnancy-related nausea (NVP), growth in surgical procedures, increased recognition of motion sickness, higher prevalence of chronic gastrointestinal disorders, and the expansion of pediatric formulations.
The nausea medicine market size is expected to see strong growth in the next few years. It will grow to $4.31 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be linked to the rising adoption of cancer treatments, regulatory focus on safer ingredients, growth of telehealth and e-prescriptions, expansion of minimally invasive surgeries, and development of hospital infrastructure. Key trends in the forecast period include the integration of digital health solutions, development of targeted therapies, shift toward personalized medicine, adoption of transdermal patches for treatment, and advancements in drug formulations.
The increasing consumption of unhealthy diets is expected to drive the growth of the nausea medicine market in the future. Unhealthy diets typically involve high intake of processed foods, sugars, unhealthy fats, and salt while lacking essential nutrients such as vitamins, minerals, and fiber. The growing preference for processed and fast foods, which are more affordable and convenient than healthier alternatives, is fueling this trend. Consuming such diets often leads to gastrointestinal discomfort, acid reflux, indigestion, and nausea. Nausea medicines, such as antiemetics, help relieve these symptoms by addressing the underlying causes, including motion sickness, gastrointestinal issues, or medication side effects. These medicines work by blocking brain signals that trigger nausea or by soothing the stomach to reduce the urge to vomit. For example, the American Journal of Preventive Medicine reported in April 2025 that over 124,000 deaths in the United States annually are linked to ultra-processed foods. As unhealthy eating habits continue to rise, the demand for nausea medicine is also increasing.
Major companies in the nausea medicine market are focusing on developing innovative solutions, such as medications for chemotherapy-induced nausea. These drugs are specifically designed to prevent or alleviate nausea and vomiting caused by cancer chemotherapy, often by targeting serotonin or neurokinin receptors in the brain. For instance, in January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched AKYNZEO I.V., a ready-to-dilute intravenous injection that combines fosnetupitant and palonosetron to prevent chemotherapy-induced nausea and vomiting (CINV). This single-dose intravenous medication offers protection against both the acute and delayed phases of CINV, simplifying treatment and improving patient compliance by reducing the need for multiple antiemetic drugs.
In June 2022, Eagle Pharmaceuticals Inc., a US-based company specializing in injectable products, acquired Acacia Pharma Group plc for an undisclosed amount. The acquisition allows Eagle Pharmaceuticals to expand its acute care and oncology portfolio by adding two FDA-approved products, while also leveraging its experienced sales team to increase market uptake. Acacia Pharma Group, a UK-based pharmaceutical company, develops and commercializes various medicines, including anti-nausea treatments.
Major players in the nausea medicine market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer Aktiengesellschaft, Merck & Co. Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Helsinn Healthcare SA, Mylan N.V., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Zydus Lifesciences Limited, Amneal Pharmaceuticals Inc.
North America was the largest region in the nausea medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nausea medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nausea medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nausea medicine market consists of sales of products including dopamine antagonists, ginger supplements, serotonin antagonists, anticholinergics, and antihistamines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nausea Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nausea medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nausea medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nausea medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Antagonists; Antagonists; Canabinoids; Other Types
2) By Indication: Oncology; Gastroesophageal Reflux Disease; Motion Sickness and Seasickness; Other Indications
3) By Route of Administration: Oral; Injectable; Transdermal; Rectal; Other Route of Administrations
4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Homecare settings; Ambulatory Surgical centres; Long-term Care Facilities; Individual Consumers
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nausea Medicine Market Characteristics
3. Nausea Medicine Market Trends And Strategies
4. Nausea Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Nausea Medicine Growth Analysis And Strategic Analysis Framework
5.1. Global Nausea Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nausea Medicine Market Growth Rate Analysis
5.4. Global Nausea Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nausea Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nausea Medicine Total Addressable Market (TAM)
6. Nausea Medicine Market Segmentation
6.1. Global Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antagonists
Antihistamines
Canabinoids
Other Types
6.2. Global Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Gastroesophageal Reflux Disease
Motion Sickness and Seasickness
Other Indications
6.3. Global Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Transdermal
Rectal
Other Route of Administrations
6.4. Global Nausea Medicine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Other Distribution Channels
6.5. Global Nausea Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare settings
Ambulatory Surgical centres
Long-term Care Facilities
Individual Consumers
6.6. Global Nausea Medicine Market, Sub-Segmentation Of Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serotonin Antagonists
Neurokinin-1 (NK1) Receptor Antagonists
Dopamine Antagonists
6.7. Global Nausea Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
H1 Antihistamines
H2 Antihistamines
6.8. Global Nausea Medicine Market, Sub-Segmentation Of Canabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
THC (Tetrahydrocannabinol)
CBD (Cannabidiol)
6.9. Global Nausea Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Benzodiazepines
Ginger-Based Medications
7. Nausea Medicine Market Regional And Country Analysis
7.1. Global Nausea Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nausea Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Nausea Medicine Market
8.1. Asia-Pacific Nausea Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nausea Medicine Market
9.1. China Nausea Medicine Market Overview
9.2. China Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nausea Medicine Market
10.1. India Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nausea Medicine Market
11.1. Japan Nausea Medicine Market Overview
11.2. Japan Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nausea Medicine Market
12.1. Australia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nausea Medicine Market
13.1. Indonesia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nausea Medicine Market
14.1. South Korea Nausea Medicine Market Overview
14.2. South Korea Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nausea Medicine Market
15.1. Western Europe Nausea Medicine Market Overview
15.2. Western Europe Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nausea Medicine Market
16.1. UK Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nausea Medicine Market
17.1. Germany Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nausea Medicine Market
18.1. France Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nausea Medicine Market
19.1. Italy Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nausea Medicine Market
20.1. Spain Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nausea Medicine Market
21.1. Eastern Europe Nausea Medicine Market Overview
21.2. Eastern Europe Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nausea Medicine Market
22.1. Russia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nausea Medicine Market
23.1. North America Nausea Medicine Market Overview
23.2. North America Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nausea Medicine Market
24.1. USA Nausea Medicine Market Overview
24.2. USA Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Nausea Medicine Market
25.1. Canada Nausea Medicine Market Overview
25.2. Canada Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nausea Medicine Market
26.1. South America Nausea Medicine Market Overview
26.2. South America Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nausea Medicine Market
27.1. Brazil Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nausea Medicine Market
28.1. Middle East Nausea Medicine Market Overview
28.2. Middle East Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nausea Medicine Market
29.1. Africa Nausea Medicine Market Overview
29.2. Africa Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nausea Medicine Market Competitive Landscape And Company Profiles
30.1. Nausea Medicine Market Competitive Landscape
30.2. Nausea Medicine Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Nausea Medicine Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. Novartis AG
31.3. AstraZeneca PLC
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Helsinn Healthcare SA
31.9. Mylan N.V.
31.10. Viatris Inc.
31.11. Baxter International Inc.
31.12. Teva Pharmaceutical Industries Limited
31.13. Sun Pharmaceutical Industries Limited
31.14. Zydus Lifesciences Limited
31.15. Amneal Pharmaceuticals Inc.
32. Global Nausea Medicine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Nausea Medicine Market
34. Recent Developments In The Nausea Medicine Market
35. Nausea Medicine Market High Potential Countries, Segments and Strategies
35.1 Nausea Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Nausea Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Nausea Medicine Market In 2029 - Growth Strategies
